Back to Search
DAVID FERNANDEZ, M.D., PH.D.
M.D., PH.D.
Rheumatology Physician
NPI: 1730406737IndividualAccepts Medicare
Education
OTHER
Class of 2010
Research & Publications (20)
Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation.
PMID 19201859·J Immunol·2009
8-other
Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus.
PMID 16947529·Arthritis Rheum·2006
8-other
Signaling abnormalities in systemic lupus erythematosus as potential drug targets.
PMID 17214576·Endocr Metab Immune Disord Drug Targets·2006
6-review
The embryo MADS domain factor AGL15 acts postembryonically. Inhibition of perianth senescence and abscission via constitutive expression.
PMID 10662856·Plant Cell·2000
8-other
Retinal neuroprotection against ischemia-reperfusion damage induced by postconditioning.
PMID 19339733·Invest Ophthalmol Vis Sci·2009
7-preclinical
T-cell and B-cell signaling biomarkers and treatment targets in lupus.
PMID 19550330·Curr Opin Rheumatol·2009
6-review
Non-invasive detection of superimposed latent fingerprints and inter-ridge trace evidence by infrared spectroscopic imaging.
PMID 19415243·Anal Bioanal Chem·2009
8-other
Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine.
PMID 19436114·J Clin Invest·2009
7-preclinical
Localization and integration of thylakoid protein translocase subunit cpTatC.
PMID 19207210·Plant J·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 535 E 70TH ST
NEW YORK, NY 10021 - Phone
- (212) 774-7016
Quick Facts
- NPI
- 1730406737
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 16
- Publications
- 20
Are you this provider?
Claim Your Profile